MIST
NASDAQ · Pharmaceuticals
Milestone Pharmaceuticals In
$0.76
+0.07 (+10.15%)
Open$0.72
Previous Close$0.69
Day High$0.77
Day Low$0.70
52W High$3.06
52W Low$0.63
Volume—
Avg Volume869.6K
Market Cap91.25M
P/E Ratio—
EPS$-0.69
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+5,855.7% upside
Current
$0.76
$0.76
Target
$45.43
$45.43
$30.70
$45.43 avg
$53.70
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.30M | 3.40M | 19.07M |
| Net Income | -94,053,501 | -125,182,122 | 5.86M |
| Profit Margin | -4,078.8% | -3,874.8% | 30.7% |
| EBITDA | -92,514,512 | -129,974,543 | 12.52M |
| Free Cash Flow | — | — | 4.46M |
| Rev Growth | -32.4% | -32.4% | +19.4% |
| Debt/Equity | 1.37 | 1.37 | 0.56 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |